|Articles|May 31, 2017
TD2 and Deep 6 AI Announce Partnership
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis.
Advertisement
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis to match eligible patients with the appropriate clinical trials.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5